Dealroom：2021年全球健康和生物科技投资报告（英文版）（30页）.pdf

《Dealroom：2021年全球健康和生物科技投资报告（英文版）（30页）.pdf》由会员分享，可在线阅读，更多相关《Dealroom：2021年全球健康和生物科技投资报告（英文版）（30页）.pdf（30页珍藏版）》请在三个皮匠报告上搜索。

1、Most global VC investment activity and value creation has predominantly been inthe engagement layer: building new user experiences.A huge opportunity remains for tech toeliminate inefficiencies and wastefulspending, while improving outcomes.Digital health is already a $350 billionmarket, growing to

2、$600 billion.ln the us alone, wasteful spending has beenestimated to be around 25-30%* with thebiggest waste category being unnecessary careand excessive admin. McKinsey reckons thathealthcare digitization lags most other sectors.According to The Economist,70% of Americanhospitals still fax and post

3、 patient records.Studies point to healthcare being only a 10-20% contributingfactor to health outcomes (quality and length of life). Socialdeterminants(employment, social care, education,neighborhood) and behaviors (smoking, diet, exercise, sexualactivity) are known to have a far greater impact on h

4、ealthoutcomes than healthcare itself.Prevention is key to lower healthcare spending. A Deloittereport projects a vision for healthcare shifting from care andtreatments dominated (83%) to health and well-beingdominated(63%). On top of prevention, another part is fasterdiagnosis and treatment with the help of Al (e.g.Babylon). Newforms of enablement, data, platforms and delivery will drive85% of revenue, Deloitte says.